Document is current
Any future updates will be listed below
-
Authors
Pucella, Joseph N. https://orcid.org/0000-0003-0875-8046
Maqueda-Alfaro, Raul A.
Ni, Hai
Bandeira Sulczewski, Fernando https://orcid.org/0000-0001-5611-6967
Eichinger, Anna https://orcid.org/0000-0002-2256-6633
Esteva, Eduardo https://orcid.org/0000-0002-7223-6632
Ra, Ai C.
Das, Annesa
Perez, Oriana A.
Feng, Jue
Stoeckius, Marlon
Smibert, Peter
Khodadadi-Jamayran, Alireza
Dolgalev, Igor https://orcid.org/0000-0003-4451-126X
Ivanova, Ellie https://orcid.org/0000-0002-1850-9505
Sota, Stela
Cadwell, Ken https://orcid.org/0000-0002-5860-0661
Koralov, Sergei B.
Zhong, Judy
Soni, Chetna
Stetson, Daniel B.
Weisberg, Stuart P. https://orcid.org/0000-0002-8698-5976
Farber, Donna L. https://orcid.org/0000-0001-8236-9183
Idoyaga, Juliana https://orcid.org/0000-0002-4430-8862
Reizis, Boris https://orcid.org/0000-0003-1140-7853
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI072571, HL145997, CA009161, CA232666, AI128949, AI128949, AI158808)
Deutsche Forschungsgemeinschaft (EI1185/1-1)
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 11 August 2025
First Online: 14 October 2025
Competing interests
: M.S. and P.S. are inventors on a patent related to the CITE-seq method and are or have been employed by 10x Genomics, Inc., but were not affiliated with it or any other commercial entity at the time of the work described in this paper. B.R. is an advisor for Related Sciences and a co-founder of Danger Bio. J.I. serves on the advisory board of Immunitas Therapeutics. None of these affiliations are related to the present work. The other authors declare no competing interests.
